PROCTER & GAMBLE HEALTH | ANUH PHARMA | PROCTER & GAMBLE HEALTH/ ANUH PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 23.6 | 146.8% | View Chart |
P/BV | x | 10.6 | 5.3 | 198.8% | View Chart |
Dividend Yield | % | 2.0 | 0.8 | 256.9% |
PROCTER & GAMBLE HEALTH ANUH PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ANUH PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ ANUH PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 110 | 4,882.3% | |
Low | Rs | 3,883 | 77 | 5,042.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 105.3 | 703.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 7.2 | 1,914.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 9.2 | 1,694.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 2.1 | 96.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 48.1 | 929.9% | |
Shares outstanding (eoy) | m | 16.60 | 50.11 | 33.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.9 | 703.2% | |
Avg P/E ratio | x | 33.5 | 12.9 | 258.4% | |
P/CF ratio (eoy) | x | 29.8 | 10.2 | 292.0% | |
Price / Book Value ratio | x | 10.3 | 1.9 | 532.1% | |
Dividend payout | % | 68.7 | 27.7 | 248.1% | |
Avg Mkt Cap | Rs m | 76,761 | 4,683 | 1,639.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 172 | 1,202.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 5,275 | 233.1% | |
Other income | Rs m | 184 | 61 | 300.7% | |
Total revenues | Rs m | 12,480 | 5,336 | 233.9% | |
Gross profit | Rs m | 3,247 | 518 | 626.8% | |
Depreciation | Rs m | 281 | 97 | 289.7% | |
Interest | Rs m | 8 | 7 | 103.2% | |
Profit before tax | Rs m | 3,142 | 475 | 661.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 113 | 750.4% | |
Profit after tax | Rs m | 2,295 | 362 | 634.2% | |
Gross profit margin | % | 26.4 | 9.8 | 268.9% | |
Effective tax rate | % | 27.0 | 23.8 | 113.4% | |
Net profit margin | % | 18.7 | 6.9 | 272.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,076 | 380.8% | |
Current liabilities | Rs m | 6,791 | 1,613 | 420.9% | |
Net working cap to sales | % | 40.0 | 27.7 | 144.3% | |
Current ratio | x | 1.7 | 1.9 | 90.5% | |
Inventory Days | Days | 263 | 66 | 400.0% | |
Debtors Days | Days | 343 | 1,185 | 29.0% | |
Net fixed assets | Rs m | 10,617 | 966 | 1,099.1% | |
Share capital | Rs m | 166 | 251 | 66.3% | |
"Free" reserves | Rs m | 7,265 | 2,162 | 336.1% | |
Net worth | Rs m | 7,431 | 2,412 | 308.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 4,042 | 552.4% | |
Interest coverage | x | 409.1 | 64.6 | 632.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.3 | 42.2% | |
Return on assets | % | 10.3 | 9.1 | 112.9% | |
Return on equity | % | 30.9 | 15.0 | 205.9% | |
Return on capital | % | 42.4 | 20.0 | 212.1% | |
Exports to sales | % | 0 | 52.5 | 0.0% | |
Imports to sales | % | 13.1 | 53.2 | 24.5% | |
Exports (fob) | Rs m | NA | 2,770 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 2,808 | 57.2% | |
Fx inflow | Rs m | 1,465 | 2,770 | 52.9% | |
Fx outflow | Rs m | 1,605 | 2,808 | 57.2% | |
Net fx | Rs m | -140 | -38 | 368.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 539 | 437.8% | |
From Investments | Rs m | -215 | -435 | 49.4% | |
From Financial Activity | Rs m | -985 | -123 | 801.4% | |
Net Cashflow | Rs m | 1,160 | -19 | -6,208.1% |
Indian Promoters | % | 0.0 | 69.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | 518,200.0% | |
Indian inst/Mut Fund | % | 20.0 | 0.1 | 14,264.3% | |
FIIs | % | 6.2 | 0.0 | 20,800.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 30.1 | 160.2% | |
Shareholders | 56,778 | 22,237 | 255.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ANUH PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.57% | 0.45% |
1-Month | -1.15% | 4.48% | 2.55% |
1-Year | 0.73% | 191.06% | 56.14% |
3-Year CAGR | -8.76% | 24.01% | 15.22% |
5-Year CAGR | 4.97% | 31.32% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ANUH PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ANUH PHARMA the stake stands at 69.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ANUH PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ANUH PHARMA paid Rs 2.0, and its dividend payout ratio stood at 27.7%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ANUH PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.